Member Info for notaflipper

Checking out the prices on BA's sale. Crazy prices. Would be surprised if any profit was being made. Looks more likely a fire sale and will be interesting to see what the operating margins will be. Frustrating news on Andrew Marr that full vaccine roll-out will only be completed by Autumn.

https://www.bbc.co.uk/news/business-55584843

Agreed. The sticky sp at these levels from mid-Dec suggests a stake is being built. Was hoping for a Holdings RNS before now. Once done the MMs will let this move, and it will move quickly. Just need to be patient.

Shorttracker still updating.
However the Excel has been updated to 05/01/21.
Shorts unchanged at 1%.
https://www.fca.org.uk/publication/data/short-positions-daily-update.xlsx

If I was a betting man with the sticky price action circa this level since the 16th Dec I would be expecting some background accumulation happening. Hopefully we'll see soon.

I had omitted in my earlier reply that we should also be expecting to hear of two US customer reproductive health contracts being announced potentially by the end of Jan or early Feb. The DPYD commercial roll-out to expand is whether there will be any further interest in the Elucigene DPYD test, which has been routinely used in Wales since October 2020, to other regions following the Clinical Commissioning Urgent Policy Statement.

With revenues increasing by 5% to £8.2m (H1 2019-20: £7.8m) by Half Year results it suggests a that the minimum FY results which could be conservatively expected is circa £17m. I suspect most would suggest though that this realistically will be over £20m+ given the reiteration of the FY targets in December when further Covid restrictions were already being introduced. This again makes the current sp disappointing for current holders. It does seem that we don't get a break either way whether Covid cases rise or fall.
GLA to ALL LTHs

Financial Armageddon hoped by some hasn't happened. I've added again at these levels. Had expected a lockdown but thought with the schools being open yesterday we could have at least a few day's break to enjoy the good news of vaccine roll-out and Brexit Deal. Worst of the macro fears are now over for me hence adding and taking off the tin hat. Very unloved and that suits me fine. Loved shares have smaller and fewer opportunities. With the Chancellor announcing £4.6bn in business grants and construction to stay open I think the market will recover given that it's a smaller lockdown and can now see an end.
Surprised more by the level of impatience on this BB if anything.
GLA

https://www.building.co.uk/news/construction-sites-to-stay-open-as-pm-orders-england-into-strictest-lockdown-since-march/5109714.article

Holders here should hear that Covid testing capacity has been further expanded to 20,000 tests per month by the end of the month as it was expected to come on stream in the third quarter. Yourgene went live with the Test to Release scheme this week, so that's an additional revenue stream. Hopefully with this confirmation we should hear of further testing expansion plans and also that growth trends in NIPT, reproductive health, oncology and research markets have been restored.
Aside from that you could hear further news on FDA accreditation of the IONA Nx and further commercial progress of the DPYD markets. With the current market capitalisation circa 4x YE forecasts this should come good by April at the latest once FY results are announced.

Stop posting to yourself.

Looks like the nerves are settling down. Good luck for all in 2021. Some great pics from around the world of the vaccine being rolled out. No doubt there will be some challenges of the vaccine roll-out and the infections in the interim. However after a few years of being bombarded by dramatic headlines on Brexit then Covid and so on, you do have to figure that from Feb 2021 onwards there will be a new beginning on a number of fronts. Good luck all.

Please don't post any non YGEN stuff here

Please don't post any non YGEN stuff here

CooperD you must be one of the biggest ******* on these BBs. I think the LTHs have demonstrated a lot, and I mean a lot of support, for this Company and are waiting for this to be repaid.

@masterblaster the Align report was not RNS'd at least not according to LSE or YGEN's own website. It was circulated by Walbrooke.

As current shareholders we may be cynical especially after the October muted results however the target audience is presumably new II investors. I suspect the News Flow should start in January here where we should see a return to our normal trading range. Upon achievement, or near achievement, of FY targets in April the Align research and sp targets will have greater credibility.

As covered it is to approve the sale of Education Software Solutions (“ESS”) business to Tiger UK Bidco Limited. The sale is conditional on the approval of Capita shareholders at a general meeting of the Company. It is an extraordinary general meeting of Capita to be held at 11:00 a.m. on 14 January 2021 at Linklaters LLP, One Silk Street, London EC2Y 8HQ (the “General Meeting”).

It is the Christmas quiet period and most are just trying to make sense of what the Brexit deal means for their respective industries hence the uncertainty in the market (e.g. in financial services). As covered there's been numerous positive developments here that still have to be appreciated in the sp, however I am still positive that this will catch up in the NY and should turn out good.

Target raised from 26.63p to 39.67p. Will be interested in whether the Brokers' targets changes in coming month. I did have to cringe when reading the 1st paragraph which put in plain daylight the opportunity lost/cost of current shareholders who had followed LR's assurances earlier in the year and kept invested here than look for opportunities elsewhere and were then disappointed in the H1 results.

To combat market pessimism, and just pure apathy now, LR could release a trading update in Jan alongside the promised Quarterly Covid update. This would then elaborate on past ambiguities like contributions to the 'moon-shot' programme as well as lab/product accreditations. This is not unprecedented in this market and is actually the norm if you look at the regularity and detail of comms for NCYT, ODX, GDR and SNG. Even newly listed Abingdon Health which has LR as a non-exec has been softly updating the market on the expected release of their AbC-19TM Rapid Antigen Test before market release. The worry otherwise will be that funds continue to be non-performing in here till FY Results April.

To meet FY targets there will have to be a spate of growth and hopefully news from the Company in the next few months.

Saw some mention of Viapath on the BB. They are a competitor on the PCR front as well as the DPYD. Pure Health is the oversight/application, Boots are the test location and Viapath is doing the testing.
https://www.boots.com/health-pharmacy-advice/pre-flight-covid-19-testing-service

Most of the coronavirus vaccines are given in two doses — typically administered three to four weeks apart — to increase antibody levels and boost your protection. That whole process typically takes about 28 days and is complete soon after you get the second shot. So you should be fully protected from COVID-19 within about a month. So the February target was probably reflecting the 1st dose administration and not reflecting the 2nd dose. Many here will have elderly or vulnerable relatives and mine are still awaiting their date.

The February target also needs to be seen in the context that even after a cure for small pox was found it still took 20years to get rid of small pox in the world. Truth is that Covid will exist in the world and many in the world will never get the vaccine as it will be too expensive. Air travel next year will continue to suffer from H&S counter measures well into next year and air corridors will need to be kept in place to allow controlled travel between countries as they progress towards full vaccination. Some countries which cannot afford to inoculate their entire population will probably have stricter travel measures. This might make sense for those countries as for example more people will die this year from malaria than Covid. We also have to figure there will need to be some compulsory legislation to mandate giving vaccines to the ant-vax lobby in
the West.

However the point is valid that the economy will have a firewall once the elderly and vulnerable are no longer at risk. To many this will again raise questions as to the whole Government's approach that has seen the wiping out many businesses and laden debt on future generations for a virus that disproportionately kills only a minority of the community.

Back to CPI...does anyone have any expectations for the 14th January GM?

It IS a Brexit sensitive stock, hence my re-entry. Those that said a No-Deal Brexit was not going to affect this stock don't remember what happened in 2016 so well. You can look at the 5-yr chart to see what happened after June 23rd 2016. The real drop came after they declared a profit warning in September 2016 due to Brexit head-winds
https://www.theguardian.com/business/2016/sep/29/capita-shares-crash-brexit-woes-vote-profit-warning

Although a deal was expected there's still a wall of money sitting on the side-lines waiting for the formal signature and acceptance by Farage and the Brexiteers. So with the vaccine roll-out and the Brexit deal done, those contracts whose signings have been pushed out due to this uncertainty can now be signed and expecting a more positive future earnings report from this. So this will have a positive effect we just need to be patient. Still expecting a Holding RNS in the next week or so.

They'll probably announce the Brexit deal after close of business. This way when the Brexiteers start jumping up and down saying Bojo buckled everyone will be distracted with Xmas. Keep calm, this will end good. GLA

Said that ESS sale would happen before Xmas. Brexit deal to happen imminently has come through. Gutted Trump lost. The only politician to call out a sham Covid relief bill. We need to appreciate how much of a drag Brexit uncertainty has been since 2016. Those that say a deal, any deal, will have minimal impact is a bit of a Grinch assessment. This will be a good deal. Let's celebrate and come together whatever our starting points.